
|Articles|November 1, 2004
D?j? vu all over again—again
Once more, the United States doesn't have enough of a vaccine—this time, flu vaccine. Just as the influenza season was about to start, the bad news hit the headlines: The entire output of the California-based Chiron company's influenza vaccine has been condemned by the authorities in the United Kingdom, where Chiron's vaccine, Fluvinir, is manufactured. US authorities had counted on 100 million doses of flu vaccine this year—up from 87 million available last year. About half that amount was to be supplied by Chiron.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
New multisociety position paper details hospital strategies to close gaps in sepsis care
2
CDC declares Nara Organics infant botulism outbreak over as genetic testing links it to 2025 ByHeart outbreak
3
What pediatricians should know for the upcoming respiratory virus season
4
FDA authorizes Avulux light-filtering lenses for migraine-associated light sensitivity in patients 12 and older
5





